AHRA’s Carlos Vasquez: The Evolving Role of Imaging Manager
AHRA President Carlos Vasquez discusses how the medical imaging manager’s role continues to evolve, driven by an increased reliance on data and the reality of having to do more with less.
The role of the medical imaging manager continues to evolve, driven by an increased reliance on data and the reality of having to do more with less.
“We need to reinvent ourselves to develop new ways to work together,” Carlos Vasquez, CRA, FAHRA, president of AHRA, the association for medical imaging management, said at the recent annual meeting in Orlando, Fla.
Here, Vasquez details the challenges facing medical imaging managers and offers some advice for thriving in this environment. Vasquez discusses:
• The need for imaging managers to arm themselves with data, and the AHRA’s new datalynx tool, developed in collaboration with Regents Health to benchmark practice operational and financial data;
• The opportunity - and challenge - for administrators to increase their visibility among hospital leadership; and
• The future of the AHRA as an advocacy organization.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
